Rare Disease Small-Batch CDMO Market Accelerate orphan drug production with flexible manufacturing and tailored CDMO partnerships
HealthcareThe rare disease small-batch CDMO market is projected to experience significant growth through 2034, driven by the increasing prevalence of rare diseases and the rising approvals of orphan drugs. With an expected compound annual growth rate (CAGR) propelled by advancements in precision medicine and specialized manufacturing, this market is becoming a critical partner for biopharma […]